Tolerance and Efficacy of Pembrolizumab or Cetuximab Combined With RT in Patients With Locally Advanced HNSCC

Clinical trial NCT02707588 · COMPLETED

Trial details

NCT number: NCT02707588
Sponsor: Groupe Oncologie Radiotherapie Tete et Cou
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Squamous Cell Carcinoma of the Head and Neck

Start date: 2016-05-18
Primary completion: 2022-10-01
Enrollment: 133

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.